Livermore, CA, United States of America

Chien-hung Chou

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.8

ph-index = 8

Forward Citations = 208(Granted Patents)


Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Chien-hung Chou in HIV Treatment**

Introduction

Chien-hung Chou is a notable inventor based in Livermore, California, known for his significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of eight patents, he has focused his research primarily on compounds for the treatment of HIV, aiming to make a substantial impact on public health.

Latest Patents

Among his latest patents, Chou has developed compounds that target the Retroviridae viral infections, specifically those caused by the HIV virus. These compounds, described by a specific formula, also include pharmaceutical compositions designed for therapeutic methods. The detailed processes for preparing these compounds and useful intermediates are also included in his patents, showcasing an extensive approach to tackling this critical health issue.

Career Highlights

Chien-hung Chou has collaborated with leading pharmaceutical companies, notably Gilead Sciences, Inc. and Sipix Imaging, Inc. His experience in these respected institutions has allowed him to refine his research and develop groundbreaking treatments for viral infections. His work reflects a commitment to advancing medical science and improving therapeutic options for patients.

Collaborations

Throughout his career, Chou has crossed paths with various professionals, including notable coworkers such as Steven S. Bondy and Winston C. Tse. These collaborations exemplify the teamwork often necessary for complex scientific advances, as they bring together diverse expertise to drive innovation in healthcare.

Conclusion

Chien-hung Chou's innovative endeavors in the field of HIV treatment highlight his significant role as an inventor. By developing therapeutic compounds and actively collaborating with industry leaders, he continues to contribute to the fight against viral infections. His work not only enhances the scientific community but also strives to improve patient outcomes in the face of challenging health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…